ULTRALIFE CORP (ULBI): Results of Operations and Financial Condition
ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: ● Sales of $47.9 million compared to $48.6 mil
How this was made
The 30-second read
Why it matters
Traders can update near-term expectations based on the reported margin expansion, adjusted EBITDA improvement, segment mix shift (Communications Systems up 39.3%), and record backlog of $117.5M.
Market read
The filing provides fresh, decision-relevant datapoints for ULBI: profitability improvement, segment growth, and backlog at the highest level in the company’s history.
What to watch
Operating expenses rose as a share of revenue, and the company cited litigation-related one-time costs tied to a cyber-insurance claim, which could complicate forward earnings quality.
Background
This is an SEC 8-K with Exhibit 99.1 reporting Ultralife’s second quarter 2026 results and financial condition.
Ticker impact
Ultralife reported Q2 revenue of $47.9M, GAAP EPS $0.15, and gross margin 28.9%, including a $1.1M IEEPA refund.
Near-term bias to the upside if investors focus on gross margin and backlog record, but tempered by flat-to-down revenue and higher opex.
The filing provides multiple concrete profitability metrics (gross margin, operating income, adjusted EBITDA) plus segment mix changes and a record backlog, which typically drive earnings revisions and sentiment for small/mid-cap industrials.
Market effects
Signals improving manufacturing efficiency and defense-related product pipeline execution for battery and communications systems suppliers.
Limited direct regional read-through; primarily company-specific profitability and backlog signal.
Defense/government program timing and tariff-related refunds (IEEPA) highlight cross-border policy sensitivity for industrial suppliers.
Counterpoint
Gross margin improvement is partly driven by a one-time IEEPA refund, so normalized margins may be less strong than headline profitability suggests.
Key entities
- companyUltralife Corporation
Reports Q2 2026 results, including gross margin expansion and record backlog, and discusses manufacturing efficiency initiatives and product pipeline.
- executiveMike Manna
CEO quoted on margin improvement initiatives and expected revenue transitions later in 2026.
